• In recent days, Core Scientific, a leading North American digital asset miner and hosting provider, has seen trading activity surge as investors react to its expanded hosting services and emphasis on greener energy across its large-scale blockchain data centers.
• This combination of broader hosting capabilities and cleaner power sources positions the company squarely within regulatory trends that are increasingly shaping how digital asset infrastructure is built and operated.
• Next, we’ll examine how Core Scientific’s push into greener, large-scale hosting could influence its longer-term investment narrative built around high-performance computing.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Core Scientific Investment Narrative Recap

To own Core Scientific, you need to believe its shift from Bitcoin mining toward high-performance computing and hosting can eventually offset persistent net losses and balance sheet fragility. The recent interest in greener, expanded hosting supports the near term catalyst of building out HPC capacity, but does not materially change the key risk around ongoing losses and the company’s limited cash runway.

Among recent announcements, the now canceled US$6.8 billion all stock acquisition agreement with CoreWeave stands out, as it directly tied to Core Scientific’s role as a large scale HPC provider. With that deal off the table, investors’ focus returns to whether existing contracts like the US$8.7 billion, 12 year CoreWeave hosting agreement and new green energy initiatives can support growth while the company works through its history of considerable net losses.

Yet beneath the appeal of greener hosting, investors should be aware of the concentrated exposure to a single major customer and the possibility that...

Core Scientific's narrative projects $1.5 billion revenue and $334.4 million earnings by 2028. This requires 60.9% yearly revenue growth and a $929.6 million earnings increase from -$595.2 million today.

Uncover how Core Scientific's forecasts yield a $26.82 fair value, a 49% upside to its current price.

Exploring Other Perspectives

Simply Wall St Community members offer three fair value estimates for Core Scientific, ranging from US$26.53 to US$37.71 per share. Against this spread, the concentration risk around CoreWeave and the company’s history of large net losses give you important context to compare these different viewpoints and consider how reliant the business may be on successful HPC execution.

Explore 3 other fair value estimates on Core Scientific - why the stock might be worth over 2x more than the current price!

Build Your Own Core Scientific Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Core Scientific research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Core Scientific research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Core Scientific's overall financial health at a glance.

Looking For Alternative Opportunities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• We've found 13 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.